Medpace Holdings, Inc.

NasdaqGS:MEDP Stock Report

Market Cap: US$17.0b

Medpace Holdings Dividends and Buybacks

Dividend criteria checks 0/6

Medpace Holdings does not have a record of paying a dividend.

Key information

n/a

Dividend yield

6.2%

Buyback Yield

Total Shareholder Yield6.2%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Medpace Stock Has Doubled: How Is The Valuation Now?

Jan 07

Earnings Not Telling The Story For Medpace Holdings, Inc. (NASDAQ:MEDP) After Shares Rise 34%

Aug 11
Earnings Not Telling The Story For Medpace Holdings, Inc. (NASDAQ:MEDP) After Shares Rise 34%

Medpace Holdings, Inc. Beat Revenue Forecasts By 12%: Here's What Analysts Are Forecasting Next

Jul 24
Medpace Holdings, Inc. Beat Revenue Forecasts By 12%: Here's What Analysts Are Forecasting Next

Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?

Jul 01
Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?

Is Medpace Holdings, Inc. (NASDAQ:MEDP) Trading At A 48% Discount?

Jun 12
Is Medpace Holdings, Inc. (NASDAQ:MEDP) Trading At A 48% Discount?

Investor Optimism Abounds Medpace Holdings, Inc. (NASDAQ:MEDP) But Growth Is Lacking

May 08
Investor Optimism Abounds Medpace Holdings, Inc. (NASDAQ:MEDP) But Growth Is Lacking

Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Apr 23
Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Is Medpace Holdings, Inc. (NASDAQ:MEDP) Potentially Undervalued?

Mar 24
Is Medpace Holdings, Inc. (NASDAQ:MEDP) Potentially Undervalued?

Medpace Holdings, Inc. Just Recorded A 5.6% EPS Beat: Here's What Analysts Are Forecasting Next

Feb 14
Medpace Holdings, Inc. Just Recorded A 5.6% EPS Beat: Here's What Analysts Are Forecasting Next

Medpace: Impressive Revenue Growth, High ROE Values, And High Growth Potential

Feb 06

Medpace: Buy The Short-Term Pain For Long-Term Gains

Oct 26

Why Medpace Holdings Is A 'Better Mousetrap'

Oct 16
User avatar

Temporary Setbacks Poised For A Swift Recovery And Strong Future Revenue Growth

Elevated project cancellations pose only a temporary risk, with potential for quick revenue and net new business awards recovery.

Medpace: Continued Business Growth With Asymmetrical Payoff Opportunity

Aug 20

Medpace: Clear Winner If China Blockade Succeeds

Jun 04

Medpace: Exceptional Performance, Almost Fully Priced In

Mar 11

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if MEDP's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MEDP's dividend payments have been increasing.


Dividend Yield vs Market

Medpace Holdings Dividend Yield vs Market
How does MEDP dividend yield compare to the market?
SegmentDividend Yield
Company (MEDP)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.3%
Industry Average (Life Sciences)0.5%
Analyst forecast (MEDP) (up to 3 years)0%

Notable Dividend: Unable to evaluate MEDP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MEDP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate MEDP's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MEDP has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/27 13:25
End of Day Share Price 2026/01/27 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medpace Holdings, Inc. is covered by 19 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eric ColdwellBaird
Luke SergottBarclays
Sean DodgeBMO Capital Markets Equity Research